09-Mar-2021 | Zion Market Research
According to the Zion Market Research forecasters, in 2018, the worth of the global cervical cancer diagnostic market was estimated to be about USD 6.92 billion and is projected to attain USD 10.99 billion by 2025, registering around of 6.1% CAGR during the forecast period. The major players participating in the global cervical cancer diagnostic market comprise Guided Therapeutics, Abbott Laboratories, Roche, Olympus, Cooper Surgical Inc, Ascon Medical Instruments, Beckman Coulter Inc., Siemens Healthcare, and Cardinal Health. There’s strong contest for cervical cancer diagnostics owing to the huge pool of cervical cancer patients. At present, firms are emphasizing on developing superior diagnosis methods such as liquid-based cytology.
Cervical cancer denotes cervical cell malignancy. The most ordinary sign of this type of cancer is vaginal bleeding; nevertheless, in a few instances, no signs are observed until cancer attains an advanced stage. Over 90% of cervical malignancies arise as a result of human papillomavirus infection and they are analyzed through smear screening.
Rising Incidence Of Cervical Cancer Across The Global To Boost The Market Growth
The growth of the global cervical cancer diagnostics market is influenced by numerous factors such as the rising incidence of cervical cancer across the world, huge pool of people affected by HPV infection, increasing count of female smokers, cancer awareness programs, rising rates of unsafe sex, specifically among youngsters, and rising obese population. Further, healthcare improvements in emerging nations and the elderly population in developed nations are also anticipated to drive the growth of the global cervical cancer diagnostics market. The presence of suitable reimbursement policies is also expected to amplify the number of screening tests in the near future. The technological developments in terms of new screening techniques, diagnostic procedures, and diagnostic tools are projected to influence the market growth positively. Nevertheless, the market growth is likely to be hampered by incorrect pap smear testing, strict government rules, fruitless healthcare infrastructure, and alternative diagnosis techniques.
Pap Smear Test To Hold The Maximum Share In The Global Market
The global cervical cancer diagnostic market is bifurcated based on age group, type, and region. The type segment of the market is categorized into ECC procedures, pap smear tests, and colposcopy tests. Among these, the most efficient tool for HPV diagnosis is the pap smear test and is projected to generate the highest revenue during the forecast period. This is primarily attributed to the increased HPV infection prevalence in females and the shortage of the HPV vaccine that doesn’t cover all kinds of HPV infections.
Escalating Cases Of HPV Infection To Drive The North America Cervical Cancer Diagnostics Market Growth
The global cervical cancer diagnostic market is expected to be ruled by North America on account of the increasing HPV infection incidence, rising aged population, and the increasing number of women smokers. Further, Asia Pacific is also anticipated to show substantial market growth as a result of enhancement in healthcare infrastructure and government initiative.
Browse the full “Cervical Cancer Diagnostics Market - Global Industry Perspective, Comprehensive Analysis And Forecast 2020-2026.” Report at https://www.zionmarketresearch.com/report/cervical-cancer-diagnostics-market
The global cervical cancer diagnostic market is segmented as follows:
By Age Group
Zion Market Research is an obligated company. We create futuristic, cutting-edge, informative reports ranging from industry reports, the company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from cardinal industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
244 Fifth Avenue, Suite N202
New York, 10001, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651